Identification of Genes Predicting Chemoresistance and Short Survival in Ovarian Cancer

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2024 Sep 12

PMID 39262489

Authors

Cong Wang

Cuilan Chen

Xiaoying Chen

Jie Luo

Yuting Su

Xia Liu

Fuqiang Yin

Affiliations

Soon will be listed here.

Abstract

Background: Ovarian cancer (OC) is a kind of lethiferous cancer in gynecology, and the development of chemoresistance is the brief reason for treatment failure. The genes which contribute to chemoresistance are often leading to short survival. Thus, this study aims to identify predictive markers for chemoresistance and survival from chemoresistant-related genes.

Methods: Coremine was used to retrieve of genes linked to OC chemoresistance. The relationship of genes with patient survival was analyzed in 489 OC patients of The Cancer Genome Atlas (TCGA) cohort, which the subgroup of 90 resistant and 197 sensitive samples was used to determine gene expression. Kaplan-Meier (KM) plotter of 1,816 OC patients with survival data was retrieved for survival analysis. Survival analysis was carried out by the R survival package in R (version 3.3.1). KM and receiver operating characteristic (ROC) curve were respectively used to access the ability of a gene to predict survival and chemoresistance.

Results: In this study, a group of genes potentially linked to OC chemoresistance was identified, which dysregulated in 90 chemoresistant tissues compared with 197 sensitive tissues. Of them, thirteen genes could predict chemoresistance in 1,347 patients, especially , , were excellent for predicting chemoresistance to any drugs, platin and taxane, and for any drugs and platin, and and for taxane. Meanwhile, 44 genes linked to OC chemoresistance could predict short overall survival (OS) and/or disease-free survival (DFS) in 489 OC patients, and 10 of them could predict short OS in large cohort of up to 1,657 patients. Finally, it is noteworthy that was down-regulated in 90 chemoresistant samples, and low expression of the gene predicted chemoresistance in 1,347 patients, short OS and DFS in 489 patients, and short OS and progression-free survival (PFS) in 1,657 patients.

Conclusions: The identified genes specifically the might be potentially used as predictive marker, prognostic marker and therapeutic target in management of OC.

References

Rung J, Brazma A . Reuse of public genome-wide gene expression data. Nat Rev Genet. 2012; 14(2):89-99. DOI: 10.1038/nrg3394. View

Fekete J, osz A, Pete I, Nagy G, Vereczkey I, Gyorffy B . Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients. Gynecol Oncol. 2020; 156(3):654-661. DOI: 10.1016/j.ygyno.2020.01.006. View

Gao C, Li H, Liu C, Xu X, Zhuang J, Zhou C . Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis. Front Immunol. 2021; 12:650491. PMC: 8097167. DOI: 10.3389/fimmu.2021.650491. View

Barrett T, Suzek T, Troup D, Wilhite S, Ngau W, Ledoux P . NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res. 2004; 33(Database issue):D562-6. PMC: 539976. DOI: 10.1093/nar/gki022. View

Xiang Y, Chen Y, Yan Y, Liu Y, Qiu J, Tan R . MiR-186 bidirectionally regulates cisplatin sensitivity of ovarian cancer cells via suppressing targets PIK3R3 and PTEN and upregulating APAF1 expression. J Cancer. 2020; 11(12):3446-3453. PMC: 7150455. DOI: 10.7150/jca.41135. View

Henderson M, Haber M, Porro A, Munoz M, Iraci N, Xue C . ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux. J Natl Cancer Inst. 2011; 103(16):1236-51. PMC: 3156802. DOI: 10.1093/jnci/djr256. View

Liu X, Gao Y, Lu Y, Zhang J, Li L, Yin F . Oncogenes associated with drug resistance in ovarian cancer. J Cancer Res Clin Oncol. 2014; 141(3):381-95. DOI: 10.1007/s00432-014-1765-5. View

Cheaib B, Auguste A, Leary A . The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges. Chin J Cancer. 2015; 34(1):4-16. PMC: 4302085. DOI: 10.5732/cjc.014.10289. View

Yang C, Matsuura K, Huang N, Robeson A, Huang B, Zhang L . Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death. Oncogene. 2014; 34(25):3264-72. PMC: 4340825. DOI: 10.1038/onc.2014.271. View

10.

Wang Z, Xu Q, Kaul D, Ismail M, Badakhshi H . Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors. Thorac Cancer. 2021; 12(13):1995-2006. PMC: 8258363. DOI: 10.1111/1759-7714.14002. View

11.

Liu M, Liu X, Liu S, Xiao F, Guo E, Qin X . Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer. Front Oncol. 2020; 10:847. PMC: 7270198. DOI: 10.3389/fonc.2020.00847. View

12.

Lou W, Ding B, Zhong G, Du C, Fan W, Fu P . Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer. Aging (Albany NY). 2019; 11(23):11416-11439. PMC: 6932902. DOI: 10.18632/aging.102538. View

13.

Liu J, Dou Y, Sheng M . Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene. Biomed Pharmacother. 2016; 83:1286-1294. DOI: 10.1016/j.biopha.2016.07.038. View

14.

Chen J, Apizi A, Wang L, Wu G, Zhu Z, Yao H . TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer. J Gastrointest Oncol. 2021; 12(5):2244-2259. PMC: 8576223. DOI: 10.21037/jgo-21-661. View

15.

Lahiani M, Eassa S, Parnell C, Nima Z, Ghosh A, Biris A . Carbon nanotubes as carriers of Panax ginseng metabolites and enhancers of ginsenosides Rb1 and Rg1 anti-cancer activity. Nanotechnology. 2016; 28(1):015101. DOI: 10.1088/0957-4484/28/1/015101. View

16.

Nunes S . Tumor Microenvironment - Selective Pressures Boosting Cancer Progression. Adv Exp Med Biol. 2020; 1219:35-49. DOI: 10.1007/978-3-030-34025-4_2. View

17.

Kao K, Vilbois S, Tsai C, Ho P . Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022; 24(11):1574-1583. DOI: 10.1038/s41556-022-01002-x. View

18.

Mangul S, Martin L, Langmead B, Sanchez-Galan J, Toma I, Hormozdiari F . How bioinformatics and open data can boost basic science in countries and universities with limited resources. Nat Biotechnol. 2019; 37(3):324-326. DOI: 10.1038/s41587-019-0053-y. View

19.

Solier S, Logette E, Desoche L, Solary E, Corcos L . Nonsense-mediated mRNA decay among human caspases: the caspase-2S putative protein is encoded by an extremely short-lived mRNA. Cell Death Differ. 2005; 12(6):687-9. DOI: 10.1038/sj.cdd.4401594. View

20.

Konstantinopoulos P, Spentzos D, Karlan B, Taniguchi T, Fountzilas E, Francoeur N . Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J Clin Oncol. 2010; 28(22):3555-61. PMC: 2917311. DOI: 10.1200/JCO.2009.27.5719. View